These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37995983)

  • 1. Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.
    Elmunzer BJ; Palsson OS; Forbes N; Zakaria A; Davis C; Canakis A; Qayed E; Bick B; Pawa S; Tierney WM; McLeod CG; Taylor J; Patel H; Mendelsohn RB; Bala G; Sloan I; Merchant AA; Smith ZL; Sendzischew Shane MA; Aroniadis OC; Ordiah CO; Ruddy JM; Simren M; Tack J; Drossman D;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1098-1107.e3. PubMed ID: 37995983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
    Ashktorab H; Challa SR; Singh G; Nanduri S; Ibrahim M; Martirosyan Z; Whitsell P; Chirumamilla LG; Shayegh N; Watson K; Smith T; Ogwo V; Kolawole O; Littleton M; Morrison N; Nair V; Byer D; Dawodu DO; Lexima P; Rashid M; Deverapalli M; Atluri SM; Nezamloo A; Nasrin F; Kim RJ; Sherif Z; Oskrochi G; Carethers JM; Brim H
    Dig Dis Sci; 2024 Feb; 69(2):562-569. PubMed ID: 38135813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19.
    Blackett JW; Li J; Jodorkovsky D; Freedberg DE
    Neurogastroenterol Motil; 2022 Mar; 34(3):e14251. PubMed ID: 34468069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal symptoms and the severity of COVID-19: Disorders of gut-brain interaction are an outcome.
    Ebrahim Nakhli R; Shanker A; Sarosiek I; Boschman J; Espino K; Sigaroodi S; Al Bayati I; Elhanafi S; Sadeghi A; Sarosiek J; Zuckerman MJ; Rezaie A; McCallum RW; Schmulson MJ; Bashashati A; Bashashati M
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14368. PubMed ID: 35383423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic, emotional, and gastrointestinal symptom severity are increased among children and adolescents with COVID-19.
    Wechsler JB; Berken JA; Keeley K; Singer W; Jhaveri R; Katz BZ; Fortunato JE; Saps M
    Neurogastroenterol Motil; 2024 Nov; 36(11):e14909. PubMed ID: 39223749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: An internet-based survey.
    Nakov R; Dimitrova-Yurukova D; Snegarova V; Nakov V; Fox M; Heinrich H
    Neurogastroenterol Motil; 2022 Feb; 34(2):e14197. PubMed ID: 34145679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global prevalence and burden of meal-related abdominal pain.
    Colomier E; Melchior C; Algera JP; Hreinsson JP; Störsrud S; Törnblom H; Van Oudenhove L; Palsson OS; Bangdiwala SI; Sperber AD; Tack J; Simrén M
    BMC Med; 2022 Feb; 20(1):71. PubMed ID: 35172840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide population prevalence and impact of sub-diagnostic gastrointestinal symptoms.
    Palsson OS; Tack J; Drossman DA; Le Nevé B; Quinquis L; Hassouna R; Ruddy J; Morris CB; Sperber AD; Bangdiwala SI; Simrén M
    Aliment Pharmacol Ther; 2024 Apr; 59(7):852-864. PubMed ID: 38311841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Gastrointestinal Symptoms at Initial Presentation with Clinical Outcomes in Hospitalized COVID-19 Patients: Results from a Large Health System in the Southern USA.
    Patel HK; Kovacic R; Chandrasekar VT; Patel SC; Singh M; Le Cam E; Burton JH; Ray A; Shah JN
    Dig Dis Sci; 2022 Nov; 67(11):5034-5043. PubMed ID: 35128607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With Cancer.
    Grover S; Redd WD; Zhou JC; Nije C; Wong D; Hathorn KE; McCarty TR; Bazarbashi AN; Shen L; Chan WW
    J Clin Gastroenterol; 2021 Jan; 55(1):84-87. PubMed ID: 33116066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and newly developed gastrointestinal symptoms after surgery for intestinal malrotation in children: Dysmotility or disorders of gut and brain interaction?
    Patel D; Banks D; Hira B; Ford M; Ambartsumyan L; Rodriguez L
    J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):827-835. PubMed ID: 38451033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome.
    Ghoshal UC; Ghoshal U
    Curr Opin Infect Dis; 2023 Oct; 36(5):366-370. PubMed ID: 37606895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aging gut: Symptoms compatible with disorders of gut-brain interaction (DGBI) in older adults in the general population.
    Busby-Whitehead J; Whitehead WE; Sperber AD; Palsson OS; Simrén M
    J Am Geriatr Soc; 2024 Feb; 72(2):479-489. PubMed ID: 37945291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of COVID-19 Patients with Gastrointestinal Symptoms.
    Montazeri M; Maghbouli N; Jamali R; Sharifi A; Pazoki M; Salimzadeh A; Barzegari B; Rafiei N; Mansouri ES; Hadadi A
    Arch Iran Med; 2021 Feb; 24(2):131-138. PubMed ID: 33636982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Midenfjord I; Borg A; Törnblom H; Simrén M
    Am J Gastroenterol; 2021 Apr; 116(4):769-779. PubMed ID: 33982947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study.
    Koloski NA; Talley NJ; Boyce PM
    Am J Gastroenterol; 2003 Apr; 98(4):789-97. PubMed ID: 12738457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain is a cardinal symptom cutting across Rome IV anatomical categories in disorders of gut-brain interaction: A network-based approach.
    Burton-Murray H; Guadagnoli L; Vanzhula IA; Brown TA; Sperber AD; Palsson O; Bangdiwala SI; Van Oudenhove L; Staller K
    Neurogastroenterol Motil; 2024 Oct; 36(10):e14877. PubMed ID: 39077969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.